Fast Track Diagnostics’ (FTD) broad range of CE-marked infectious disease detection tests and syndromic panels¹ expands the Siemens Healthineers molecular diagnostics portfolio

FTD’s kits can distinguish between multiple infections through a single test. Siemens Healthineers has signed an agreement to acquire Luxembourg-based Fast Track Diagnostics (FTD), a global supplier of diagnostics tests that, unlike a clinical examination alone, can distinguish between viral, bacterial, or other infections in one test...

Siemens Healthineers have announced the CE Mark and global commercial availability of its Atellica™ Solution - flexible, scalable, automation-ready immunoassay and chemistry analysers. The solution is now available across the globe in Europe, the United States, South America and Asia.

The Atellica Solution provides laboratory diagnostics professionals control and simplicity so they can spend more time driving outcomes and less time on operations. “The launch of the game-changing Atellica Solution revolutionises sample management and provides customers....

Siemens Healthineers brings FTD’s assays and multisyndromic panels onto expanded menu for VERSANT® kPCR Molecular System

In an effort to provide customers with expanded, more comprehensive solutions for molecular testing, Siemens Healthineers announces a new strategic relationship with Fast-track Diagnostics (FTD) that includes the addition of FTD’s broad range of CE-marked kits and multisyndromic panels to the menu of the Siemens Healthineers VERSANT® kPCR Molecular System....

Project will explore quantitative MRI metrics for more informed treatment decision making

Siemens Healthineersand Biogen announced today that the companies plan to jointly develop Magnetic Resonance Imaging (MRI) applications with the intent of quantifying key markers of multiple sclerosis (MS) disease activity and progression. Biogen is a leading biotechnology company with a deep focus on neurological and autoimmune conditions....

Siemens Healthineers has been collaborating with the University of Cambridge to install a new type of MRI scanner, which will allow researchers to see detail in the brain as tiny as a grain of sand.

The Siemens 7T Terra MRI has the potential to bring a new era of personalised treatments to major illnesses, including cancer, dementia and mental health conditions. The cutting-edge machinery gives researchers the opportunity to study how the brain encodes information, including things like individual memories. This means the scanner will now be able to now pick up on extremely small structures, including those associated with the early stages of Alzheimer...

Siemens new RAPIDComm^® Data Management and Connectivity Solution Version 3.0  provides point-of-care coordinators and laboratory managers a single interface with real-time access for managing multiple remote Siemens blood gas and urine analyzers-standardizing testing procedures, facilitating compliance and improving risk management for point-of-care testing.